Type 1 diabetes (T1D) is an autoimmune disease that is usually diagnosed in children and young adults. For those with the disease, the pancreas stops producing insulin. Without insulin, the body is unable to break down and store energy (in the form of glucose or “sugar”) from food. Thus, high levels of fat and glucose remain in the blood stream, which can damage blood vessels and vital organs over time. Type 1 diabetes can cause complications even if insulin levels are maintained.
Symptoms of type 1 diabetes range from increased thirst, fatigue, hunger, and sweating to nausea, vomiting, and excessive urination. Only a doctor can determine if someone has T1D. There is no cure for type 1 diabetes, and managing the disease requires multiple daily insulin injections with pens, syringes, or pumps.
That’s where the T1GER study comes in. The purpose of the T1GER clinical research study is to determine the safety and efficacy of an investigational medication in children and young adults with newly diagnosed type 1 diabetes. The investigational medication is being tested to find out if it can maintain beta cell (insulin-producing) function in the pancreas of those newly diagnosed with type 1 diabetes.
Learn more about the T1GER study